InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. BetaShares Digital Health and Telemedicine ETF (EDOC)
  6. Fund details

BetaShares Digital Health and Telemedicine ETF (ASX: EDOC) - Share Price and Research

Current share price for EDOC : $10.300 0.16 (1.58%)+

BetaShares Digital Health and Telemedicine ETF (EDOC) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. BetaShares Digital Health and Telemedicine ETF (EDOC) aims to track the performance of an index (before fees and expenses) that provides exposure to a portfolio of global digital healthcare companies from sectors such as telehealth, medical devices, wearables, remote patient monitoring, and digital healthcare software. Betashares is a leading Australian fund manager, with a focus on exchange traded funds (ETFs).

General Information

BetaShares Digital Health and Tmdcn ETF
BetaShares Capital Ltd
Equity World Other
MSCI World Ex Australia NR AUD
starstar
Not Rated
Investment Fund
28 Mar 2022
$1.63 million (as at 13 Dec 2024)
$9.59 (as at 30 Aug 2023)
$9.59 (as at 30 Aug 2023)

EDOC ETF performance (30 Nov 2024)

NOTE : returns for periods greater than 1 year are annualised
  1 Month % 3 Month % 6 Month % 1 Year % p.a. 2 Year % p.a. 3 Year % p.a. 5 Year % p.a. 10 Year % p.a.
Total return 9.39 18.46 15.3 14.01 -3.94 - - -
Growth return 9.39 18.46 15.3 14.01 -3.94 - - -
Income return (Yield) 0 0 0 0 0 - - -

Market index (MSCI World Ex Australia NR AUD)
Total return 5.18 8.79 13.61 30.23 22.04 11.92 13.37 13.17

Asset Allocation (30 Nov 2024)

Australian Equities 0%
International Equities 99.65%
Cash 0.35%
Property 0%
Fixed Interest 0%
Alternatives 0%
Asset Allocation

Objectives and Strategy

The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the 'Index'), before taking into account fees and expenses.
The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the 'Index'), before taking into account fees and expenses.

Offer information

MER 0.67% (as at 18 Oct 2023)
Indirect Cost Ratio (ICR) 0.67% (as at 30 Jun 2023)
Performance fee (not included in ICR) Not Available

Top 10 holdings (as at 30 Nov 2024)

Holding Type % of Portfolio
Insulet Corp Equity 9.56%
Login now to view the complete list of holdings.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.